Medpace Holdings Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 40.92
Dividend & YieldN/A$ (N/A)
Beta 1.47
Market capitalization 6.45B
Operating cash flow 322.26M
ESG Scores unknown

Company description

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

Sector: Healthcare - Industry: Diagnostics & Research

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 36.94M 49.31M 60.81M 90.84M
Total Cashflows From Investing Activities -16.97M -19.14M -31.21M -31.36M
Net Borrowings -144.07M -80.44M
Total Cash From Financing Activities -141.58M -73.92M -82.28M -44.45M
Change To Operating Activities 29.71M 7.53M 10.98M 846k
Issuance Of Stock 2.49M 6.52M 15.99M 17.64M
Net Income 73.19M 100.44M 145.38M 181.85M
Change In Cash -3.21M 108.64M 145.85M 183.54M
Effect Of Exchange Rate -1.24M -167k 666k -3.97M
Total Cash From Operating Activities 156.58M 201.87M 258.68M 263.33M
Depreciation 38.8M 23.19M 19.53M 21.12M
Change To Account Receivables -27.05M -21.26M -5.53M -24.98M
Other Cashflows From Financing Activities
Change To Netincome 4.38M 41.69M 27.51M -6.35M
Capital Expenditures -16.02M -17.91M -31.34M -28.27M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development
Income Before Tax 93.95M 124.83M 168.53M 201.85M
Net Income 73.19M 100.44M 145.38M 181.85M
Selling General Administrative 75.68M 95.25M 92.16M 108.42M
Gross Profit 452.31M 539.96M 571.5M 701.29M
Ebit 101.05M 127.26M 167.04M 198.62M
Operating Income 101.05M 127.26M 167.04M 198.62M
Interest Expense -8.16M -1.57M -105k -105k
Income Tax Expense 20.77M 24.39M 23.15M 20M
Total Revenue 704.59M 860.97M 925.92M 1.14B
Cost Of Revenue 252.28M 321.01M 354.43M 441.09M
Total Other Income ExpenseNet -7.1M -2.43M 1.49M 3.24M
Net Income From Continuing Ops 73.19M 100.44M 145.38M 181.85M
Net Income Applicable To Common Shares 72.89M 100.16M 144.93M 181.39M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 378.23M 416.79M 584.9M 707.01M
Total Stockholder Equity 589.7M 726.28M 805.78M 952.93M
Other Current Liabilities 150.7M 200.37M 263.3M 355.98M
Total Assets 967.93M 1.14B 1.39B 1.66B
Common Stock 356k 360k 355k 360k
Other Current Assets 7k
Retained Earnings -41.49M 68.11M 115.23M 234.98M
Treasury Stock -8.55M -8.77M -5.71M -10.27M
Cash 23.27M 131.92M 277.77M 461.3M
Total Current Liabilities 257.03M 343M 440.11M 557.22M
Other Stockholder Equity -2.52M -2.74M -131k -4.85M
Property, Plant, and Equipment 52.26M 99.44M 198.83M 222.71M
Total Current Assets 178.11M 317.03M 473.65M 690.91M
Net Tangible Assets -140.46M 9.54M 96.91M 249.17M
Net Receivables 133.45M 155.66M 160.96M 186.43M
Accounts Payable 16.74M 22.4M 26.55M 25.68M


Insider Transactions

Here are the insider transactions of stock shares related to Medpace Holdings Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
BRADY KEVIN M.Sale at price 227.09 - 229.30 per share.D2022-11-16Chief Financial Officer2k
GEIGER JESSE JSale at price 230.00 per share.D2022-11-15President7k
GEIGER JESSE JConversion of Exercise of derivative security at price 28.32 per share.D2022-11-15President7k
KRAFT ROBERT OSale at price 221.42 per share.D2022-11-01Director9.63k
KRAFT ROBERT OConversion of Exercise of derivative security at price 23.00 per share.D2022-11-01Director9.63k
EWALD STEPHEN PSale at price 220.53 per share.D2022-10-27General Counsel6.5k
EWALD STEPHEN PConversion of Exercise of derivative security at price 32.05 per share.D2022-10-27General Counsel6.5k
TROENDLE AUGUST JPurchase at price 154.59 per share.I2022-09-22Chief Executive Officer57.43k
MEDPACE INVESTORS, L.L.C.Purchase at price 154.59 per share.D2022-09-22Beneficial Owner of more than 10% of a Class of Security57.43k
TROENDLE AUGUST JPurchase at price 155.14 - 161.63 per share.I2022-09-21Chief Executive Officer188.24k
MEDPACE INVESTORS, L.L.C.Purchase at price 155.14 - 161.63 per share.D2022-09-21Beneficial Owner of more than 10% of a Class of Security188.24k
TROENDLE AUGUST JPurchase at price 149.58 - 153.48 per share.I2022-09-19Chief Executive Officer156.63k
MEDPACE INVESTORS, L.L.C.Purchase at price 149.58 - 153.48 per share.D2022-09-19Beneficial Owner of more than 10% of a Class of Security156.63k
TROENDLE AUGUST JPurchase at price 152.66 - 153.11 per share.I2022-09-15Chief Executive Officer125.03k
MEDPACE INVESTORS, L.L.C.Purchase at price 152.66 - 153.11 per share.D2022-09-15Beneficial Owner of more than 10% of a Class of Security125.03k
TROENDLE AUGUST JPurchase at price 157.12 - 167.58 per share.I2022-09-13Chief Executive Officer125.03k
MEDPACE INVESTORS, L.L.C.Purchase at price 157.12 - 167.58 per share.D2022-09-13Beneficial Owner of more than 10% of a Class of Security125.03k
TROENDLE AUGUST JPurchase at price 157.65 - 164.33 per share.I2022-09-09Chief Executive Officer113.11k
MEDPACE INVESTORS, L.L.C.Purchase at price 157.65 - 164.33 per share.D2022-09-09Beneficial Owner of more than 10% of a Class of Security113.11k
TROENDLE AUGUST JPurchase at price 147.59 - 150.72 per share.I2022-09-07Chief Executive Officer113.11k
MEDPACE INVESTORS, L.L.C.Purchase at price 147.59 - 150.72 per share.D2022-09-07Beneficial Owner of more than 10% of a Class of Security113.11k
TROENDLE AUGUST JPurchase at price 144.52 - 144.98 per share.I2022-09-02Chief Executive Officer90.79k
MEDPACE INVESTORS, L.L.C.Purchase at price 144.52 - 144.98 per share.D2022-09-02Beneficial Owner of more than 10% of a Class of Security90.79k
TROENDLE AUGUST JPurchase at price 145.00 per share.I2022-07-18Chief Executive Officer8.33k
MEDPACE INVESTORS, L.L.C.Purchase at price 145.00 per share.D2022-07-18Beneficial Owner of more than 10% of a Class of Security8.33k
TROENDLE AUGUST JPurchase at price 144.59 per share.I2022-07-14Chief Executive Officer22.29k
MEDPACE INVESTORS, L.L.C.Purchase at price 144.59 per share.D2022-07-14Beneficial Owner of more than 10% of a Class of Security22.29k
EWALD STEPHEN PConversion of Exercise of derivative security at price 32.05 per share.D2022-05-06General Counsel1k
TROENDLE AUGUST JConversion of Exercise of derivative security at price 90.65 per share.D2022-03-01Chief Executive Officer100k
BURWIG SUSAN ELIZABETHConversion of Exercise of derivative security at price 28.32 per share.D2022-02-23Officer12.4k
DAVENPORT FRED B JRPurchase at price 145.80 per share.I2022-02-17Director500
TROENDLE AUGUST JSale at price 213.44 per share.I2022-01-04Chief Executive Officer3.34k
MEDPACE INVESTORS, L.L.C.Sale at price 213.44 per share.D2022-01-04Beneficial Owner of more than 10% of a Class of Security3.34k
TROENDLE AUGUST JSale at price 212.70 - 220.34 per share.I2022-01-03Chief Executive Officer50.19k
MEDPACE INVESTORS, L.L.C.Sale at price 212.70 - 220.34 per share.D2022-01-03Beneficial Owner of more than 10% of a Class of Security50.19k
TROENDLE AUGUST JSale at price 220.16 - 222.18 per share.I2021-12-29Chief Executive Officer40.87k
MEDPACE INVESTORS, L.L.C.Sale at price 220.16 - 222.18 per share.D2021-12-29Beneficial Owner of more than 10% of a Class of Security40.87k
TROENDLE AUGUST JSale at price 223.19 - 226.11 per share.I2021-12-27Chief Executive Officer62k
MEDPACE INVESTORS, L.L.C.Sale at price 223.19 - 226.11 per share.D2021-12-27Beneficial Owner of more than 10% of a Class of Security62k
TROENDLE AUGUST JSale at price 215.17 - 220.50 per share.I2021-12-22Chief Executive Officer57.09k
MEDPACE INVESTORS, L.L.C.Sale at price 215.17 - 220.50 per share.D2021-12-22Beneficial Owner of more than 10% of a Class of Security57.09k
TROENDLE AUGUST JSale at price 212.57 - 213.59 per share.I2021-12-20Chief Executive Officer53.34k
MEDPACE INVESTORS, L.L.C.Sale at price 212.57 - 213.59 per share.D2021-12-20Beneficial Owner of more than 10% of a Class of Security53.34k
TROENDLE AUGUST JSale at price 210.22 - 210.28 per share.I2021-12-16Chief Executive Officer8.38k
MEDPACE INVESTORS, L.L.C.Sale at price 210.22 - 210.28 per share.D2021-12-16Beneficial Owner of more than 10% of a Class of Security8.38k
TROENDLE AUGUST JSale at price 210.20 - 212.13 per share.I2021-12-10Chief Executive Officer15.3k
MEDPACE INVESTORS, L.L.C.Sale at price 210.20 - 212.13 per share.D2021-12-10Beneficial Owner of more than 10% of a Class of Security15.3k
TROENDLE AUGUST JSale at price 211.78 - 212.89 per share.I2021-12-08Chief Executive Officer34.39k
MEDPACE INVESTORS, L.L.C.Sale at price 211.78 - 212.89 per share.D2021-12-08Beneficial Owner of more than 10% of a Class of Security34.39k
TROENDLE AUGUST JSale at price 211.48 per share.I2021-12-03Chief Executive Officer400
MEDPACE INVESTORS, L.L.C.Sale at price 211.48 per share.D2021-12-03Beneficial Owner of more than 10% of a Class of Security400

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Medpace Holdings Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Medpace Holdings Inc

Here is the result of two systematic investment strategies applied to Medpace Holdings Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Medpace Holdings Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Medpace Holdings Inc:

Medpace Holdings Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 170.63% on the backtest period.

Performance at glance

Performance

170.63 %

Latent gain

3874.03 $

Invested capital

2270.48 $

Annualized return

41.21 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Medpace Holdings Inc

This is the result of two momentum investment strategies applied to Medpace Holdings Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Medpace Holdings Inc

The following chart shows all the entries opened by the momentum investment system on Medpace Holdings Inc:

Medpace Holdings Inc momentum entries
  • The first momentum investment strategy would give 215.57% of return on Medpace Holdings Inc. That represents 9478.02$ of latent gain with 4396.68$ of employed capital.
  • The second momentum investment strategy would give 181.86% of return on Medpace Holdings Inc. That represents 8056.97$ of latent gain with 4430.26$ of employed capital.
Performance at glance (1Q Momentum)

Performance

215.57 %

Latent gain

9478.02 $

Invested capital

4396.68 $

Annualized return

9.31 %
Performance at glance (2Q Momentum)

Performance

181.86 %

Latent gain

8056.97 $

Invested capital

4430.26 $

Annualized return

49.69 %

Momentum equity curve on Medpace Holdings Inc

The following chart shows the equity curve of the two momentum strategies applied to Medpace Holdings Inc:

Medpace Holdings Inc momentum equity

Note: the dividends potentially given by Medpace Holdings Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Medpace Holdings Inc

The following chart shows the employed capital evolution of the two momentum strategies on Medpace Holdings Inc since the beginning:

Medpace Holdings Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Medpace Holdings Inc

Buy the dip entry openings on Medpace Holdings Inc

Medpace Holdings Inc

The performance achieved by the robo-advisor on Medpace Holdings Inc is 19.92%. That represents 65.86$ of latent gain with 330.56$ of employed capital. The following chart shows Medpace Holdings Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Medpace Holdings Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

19.92 %

Latent gain

65.86 $

Invested capital

330.56 $

Annualized return

9.31 %

Equity curve of the strategy applied to Medpace Holdings Inc

The following chart shows the result of the investment strategy applied to Medpace Holdings Inc:

Medpace Holdings Inc

Note: the dividends potentially given by Medpace Holdings Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Medpace Holdings Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Medpace Holdings Inc:

Medpace Holdings Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Medpace Holdings Inc

In this section, I will compare the three previous investment strategies applied to Medpace Holdings Inc.

Equity curve comparison on Medpace Holdings Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Medpace Holdings Inc investment strategy comparison

Employed capital comparison on Medpace Holdings Inc

Medpace Holdings Inc investment comparison

Performance comparison on Medpace Holdings Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 170.63% 3874.03$ 2270.48$ 41.21%
Momentum 1 quarter 215.57% 9478.02$ 4396.68$ 55.27%
Momentum 2 quarters 181.86% 8056.97$ 4430.26$ 49.69%
Non-directional 19.92% 65.86$ 330.56$ 9.31%
Annualized return comparison

Automatic investment

41.21 %

Momentum 1Q

49.69 %

Momentum 2Q

49.69 %

Non-directional

9.31 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Medpace Holdings Inc:

Positive correlations

Most correlated stocks this year

  • Medpace Holdings Inc

  • Most correlated stocks last 3 months

  • AIRBOSS AMERICA J
  • Albemarle Corp
  • CVS Health Corp
  • El Pollo Loco Holdings Inc
  • Fox Factory Holding Corp
  • LITHIUM AMERICAS CORP
  • First Trust Consumer Staples AlphaDEX Fund
  • Lithium Americas Corp
  • VanEck Rare Earth/Strategic Metals ETF
  • U.S. Global Investors Inc - Class A
  • Invesco DWA Consumer Staples Momentum ETF
  • Icahn Enterprises L P
  • Acadia Healthcare Company Inc
  • First Trust Germany AlphaDEX Fund
  • Amplify Lithium & Battery Technology ETF
  • SMITHS GROUP PLC ORD 37.5P
  • First Trust BICK Index Fund
  • Ceva Inc
  • FIRST TRUST RIVERFRONT DYNAMIC EMERGING MARKETS ET
  • iShare Inc iShares ESG Aware MSCI EM ETF
  • News Corp - Class A
  • News Corp - Class B
  • SOLID STATE PLC ORD 5P
  • Darling Ingredients Inc
  • Invesco S&P MidCap 400 Pure Growth ETF
  • Expeditors International Of Washington Inc
  • First Trust Indxx NextG ETF
  • BorgWarner Inc
  • Saia Inc
  • PennantPark Floating Rate Capital Ltd
  • Invesco DWA SmallCap Momentum ETF
  • Fortune Brands Home & Security Inc
  • First Trust Capital Strength ETF
  • FIRST TRUST NASDAQ ARTIFICIAL INTELLIGENCE AND ROB
  • Janus Henderson Small/Mid Cap Growth Alpha ETF
  • Janus Henderson Small Cap Growth Alpha ETF
  • Global X Funds Global X Internet of Things ETF
  • Vanguard Russell 2000 Growth Index ETF
  • MSC Industrial Direct Co. Inc - Class A
  • Invesco DB G10 Currency Harvest Fund
  • TriplePoint Venture Growth BDC Corp
  • Cintas Corporation
  • PGT Innovations Inc
  • Qwest Corporation
  • iShares Core MSCI Total International Stock ETF
  • Vanguard Total International Stock ETF
  • Global X Autonomous & Electric Vehicles ETF
  • Global X Funds Global X Robotics & Artificial Inte
  • First Trust Nasdaq Semiconductor ETF
  • Skyworks Solutions Inc
  • Siren Nasdaq NexGen Economy ETF
  • iShares MSCI Global Sustainable Development Goals
  • Equifax Inc
  • Syneos Health Inc - Class A
  • iShares MSCI Netherlands ETF
  • Quaker Houghton
  • iShares MSCI ACWI ETF
  • iShares Semiconductor ETF
  • Direxion Daily Semiconductor Bull 3X Shares
  • ETCT ROBO Global Robotics and Automation Index ETF
  • Gabelli Healthcare & WellnessRx Trust
  • VanEck Semiconductor ETF
  • First Trust Multi Cap Growth AlphaDEX Fund
  • Archrock Inc
  • Royce Global Value Trust Inc
  • Davis Select Worldwide ETF
  • ADVISORSHARES DORSEY WRIGHT MICRO-CAP ETF
  • Chipotle Mexican Grill
  • Fidelity MSCI Communication Services Index ETF
  • Invesco DWA Developed Markets Momentum ETF
  • First Trust Nasdaq Food & Beverage ETF
  • United Micro Electronics
  • Chemours Company
  • Axalta Coating Systems Ltd
  • Molina Healthcare Inc
  • AEM
  • Ameresco Inc - Class A
  • Visa Inc - Class A
  • Surface Oncology Inc
  • Global X MSCI Argentina ETF
  • Broadridge Financial Solutions Inc
  • WISDOMTREE EMERGING MARKETS MULTIFACTOR FUND N/A
  • WISDOMTREE EMERGING MARKETS QUALITY DIVIDEND GROWT
  • SPDR Portfolio Emerging Markets ETF
  • PROSHARES ULTRA MSCI EMERGING MARKETS
  • Invesco DWA Emerging Markets Momentum ETF
  • WisdomTree Emerging Markets SmallCap Dividend Fund
  • iShares MSCI Emerging Markets ETF
  • Waste Connections Inc
  • iShares MSCI Emerging Markets Small-Cap ETF
  • American Superconductor Corp
  • CIENA Corp
  • First Trust Nasdaq Clean Edge Green Energy Index F
  • Impact Shares Sustainable Development Goals Global
  • VanEck Low Carbon Energy ETF
  • TD Synnex Corp
  • SPDR SSGA Gender Diversity Index ETF
  • First Trust Mid Cap Growth AlphaDEX Fund
  • Invesco Solar ETF
  • iShares Global Clean Energy ETF
  • Heska Corp (Restricted Voting)
  • Fidelity MSCI Health Care Index ETF
  • First Trust Health Care AlphaDEX Fund
  • iShares Exponential Technologies ETF
  • Home Depot Inc
  • First Trust Nasdaq-100 Ex-Technology Sector Index
  • Principal U.S. Mega-Cap ETF
  • Invesco S&P 500 Pure Growth ETF
  • Invesco DWA Momentum ETF
  • Fidelity Momentum Factor ETF
  • Global X Millennial Consumer ETF
  • VanEck Retail ETF
  • iShares Core S&P U.S.Growth ETF
  • Medpace Holdings Inc
  • First Trust NASDAQ Cybersecurity ETF
  • ClearBridge All Cap Growth ESG ETF
  • Global X S&P 500 Catholic Values ETF
  • First Trust Dorsey Wright Focus 5 ETF
  • ClearBridge Large Cap Growth ESG ETF
  • First Trust NASDAQ-100 Equal Weighted Index Fund
  • First Trust NASDAQ-100 Technology Sector Index Fun
  • iShares Trust iShares ESG Aware MSCI USA ETF
  • Vanguard Russell 1000 Index ETF
  • Schwab 1000 Index ETF
  • Schwab U.S. Large-Cap ETF
  • MSCI USA ESG Select ETF
  • Fidelity MSCI Consumer Discretionary Index ETF
  • iShares Global Consumer Discretionary ETF
  • Invesco S&P 500 Equal Weight Technology ETF
  • Thermo Fisher Scientific Inc
  • Ultra Clean Hldgs Inc
  • iShares MSCI New Zealand ETF
  • ERShares Entrepreneurs ETF
  • Accenture plc - Class A
  • WisdomTree Global ex-U.S. Quality Dividend Growth
  • Mastercard Incorporated - Class A

  • Note: The algorithm computes the probability of correlation between Medpace Holdings Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Medpace Holdings Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name Medpace Holdings Inc
    Country United States
    City Cincinnati
    Address 5375 Medpace Way
    Phone 513 579 9911
    Website www.medpace.com
    FullTime employees 5000
    Industry Diagnostics & Research
    Sector Healthcare
    Exchange XNAS
    Ticker MEDP
    Market www.nasdaq.com

    Medpace Holdings Inc ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown